Medical University of Bialystok at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Medical University of Bialystok brings 2 presentations to SITC 2026 in Phoenix. Its program centres on pairing new chemical compounds with HER2 antibodies in HER2-positive stomach cancer. The compounds work alongside trastuzumab, and in one case pertuzumab, to curb markers of immune evasion and strengthen anti-tumor effects.
| Organization | SITC 2026 Attendance |
|---|---|
Medical University of Bialystok Białystok, Poland | |
A Polish medical university conducting biomedical research and training health professionals. | Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm |
Instantly find 20 buyers from Medical University of Bialystok
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction